phenylbutyric acid

  1. A

    FDA advisers narrowly side against an experimental ALS drug

    https://www.nytimes.com/2022/03/30/health/als-treatment-amx0035.html By a narrow margin, a federal panel of independent medical experts concluded Wednesday that there is not yet enough evidence that an experimental therapy for amyotrophic lateral sclerosis, commonly known as A.L.S., is effective...
Back
Top Bottom